(S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats

Carcinogenesis

Volumn 34, Issue 9, 2013, Pages 2178-2183

  Balbo, Silvia ^a   James Yi, Sandra ^a   Johnson, Charles S ^a   O'Sullivan, Michael G ^a   Stepanov, Irina ^a   Wang, Mingyao ^a   Bandyopadhyay, Dipankar ^a   Kassie, Fekadu ^a   Carmella, Steven ^a   Upadhyaya, Pramod ^a   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; NITROSONORNICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER LOCALIZATION; CARCINOGEN TESTING; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENANTIOMER; ESOPHAGUS TUMOR; HISTOPATHOLOGY; MALE; MOUTH CANCER; MOUTH CAVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKELESS TOBACCO;

ANIMALS; CARCINOGENS; HUMANS; MALE; MOUTH; MOUTH NEOPLASMS; NITROSAMINES; RATS; STEREOISOMERISM; TOBACCO, SMOKELESS;

EID: 84886666568     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt162     Document Type: Article

References (41)

1. IARC (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 89. International Agency for Research on Cancer, Lyon.
2. Centers for Disease Control and Prevention. Smokeless Tobacco Facts. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/smokeless/smokeless_ facts/(31 January 2012, date last accessed).
3. United States Department of Health and Human Services (2012) Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. U.S. Department of Health and Human Services, Washington, DC.
4. United States Surgeon General (1986) The Health Consequences of Using Smokeless Tobacco. U.S. Department of Health and Human Services, Washington, DC.
5. Boffetta, P. et al. (2008) Smokeless tobacco and cancer. Lancet Oncol., 9, 667-675.
6. Jemal, A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
7. Rethman, M.P. et al. (2012) Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Tex. Dent. J., 129, 491-507.
8. Hoffmann, D. et al. (1974) N'-nitrosonornicotine in tobacco. Science, 186, 265-267.
9. Stepanov, I. et al. (2012) Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus. Nicotine Tob. Res., 14, 1241-1245.
10. Stepanov, I. et al. (2012) Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch. Nicotine Tob. Res., 14, 274-281.
11. Stanfill, S.B. et al. (2011) Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob. Control, 20, e2.
12. Richter, P. et al. (2008) Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nicotine Tob. Res., 10, 1645-1652.
13. Carmella, S.G. et al. (2000) Enantiomeric composition of N'-nitrosonornicotine and N'-nitrosoanatabine in tobacco. Carcinogenesis, 21, 839-843.
14. Stepanov, I. et al. (2013) Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products. Nicotine Tob. Res.
15. Hecht, S.S. (1998) Biochemistry, biology, and carcinogenicity of tobaccospecific N-nitrosamines. Chem. Res. Toxicol., 11, 559-603.
16. Lao, Y. et al. (2007) Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N'-nitrosonornicotine. Chem. Res. Toxicol., 20, 246-256.
17. Zhang, S. et al. (2009) Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem. Res. Toxicol., 22, 926-936.
18. McIntee, E.J. et al. (2000) Metabolism of N'-nitrosonornicotine enantiomers by cultured rat esophagus and in vivo in rats. Chem. Res. Toxicol., 13, 192-199.
19. Seeman, J.I. et al. (1985) Synthesis of the enantiomers of nornicotine. J. Org. Chem., 50, 5419-5421.
20. Murphy, S.E. et al. (1990) Comparative metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus. Cancer Res., 50, 4685-4691.
21. Stepanov, I. et al. (2013) Analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing DNA adducts in human exfoliated oral mucosa cells by liquid chromatography-electrospray ionization-tandem mass spectrometry. Chem. Res. Toxicol.
22. Hoffmann, D. et al. (1975) A study of tobacco carcinogenesis. XIV. Effects of N'-nitrosonornicotine and N'-nitrosonanabasine in rats. J. Natl Cancer Inst., 55, 977-981.
23. Hecht, S.S. et al. (1983) Comparative carcinogenicity in F344 rats and Syrian golden hamsters of N'-nitrosonornicotine and N'-nitrosonornicotine- 1-N-oxide. Cancer Lett., 20, 333-340.
24. Castonguay, A. et al. (1984) Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N'-nitrosonornicotine in F344 rats. Cancer Res., 44, 2285-2290.
25. Stoner, G.D. et al. (1998) Inhibition of N'-nitrosonornicotine-induced esophageal tumorigenesis by 3-phenylpropyl isothiocyanate. Carcinogenesis, 19, 2139-2143.
26. Hecht, S.S. et al. (1986) Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res., 46, 4162-4166.
27. Prokopczyk, B. et al. (1991) A study of betel quid carcinogenesis. IX. Comparative carcinogenicity of 3-(methylnitrosamino)propionitrile and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone upon local application to mouse skin and rat oral mucosa. Cancer Lett., 60, 153-157.
28. Guo, Y. et al. (2011) Ethanol promotes chemically induced oral cancer in mice through activation of the 5-lipoxygenase pathway of arachidonic acid metabolism. Cancer Prev. Res. (Phila)., 4, 1863-1872.
29. Fong, L.Y. et al. (2011) Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis. Carcinogenesis, 32, 554-560.
30. Kanojia, D. et al. (2006) 4-Nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol., 42, 655-667.
31. Gimenez-Conti, I.B. et al. (1992) The hamster cheek pouch model of carcinogenesis and chemoprevention. Adv. Exp. Med. Biol., 320, 63-67.
32. Guttenplan, J.B. et al. (2012) Mutagenesis and carcinogenesis induced by dibenzo[a, l]pyrene in the mouse oral cavity: a potential new model for oral cancer. Int. J. Cancer, 130, 2783-2790.
33. Stepanov, I. et al. (2010) Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry. Chem. Res. Toxicol., 23, 66-73.
34. Hecht, S.S. et al. (2008) Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco. Tob. Control, 17, 128-131.
35. Hecht, S.S. et al. (2011) Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products. Tob. Control, 20, 443.
36. Hecht, S.S. et al. (2008) Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. Cancer Epidemiol. Biomarkers Prev., 17, 732-735.
37. IARC (2004) Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 83. International Agency for Research on Cancer, Lyon, pp. 53-1187.
38. Hecht, S.S. (2012) Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine Tob. Res., 14, 18-28.
39. Stepanov, I. et al. (2012) Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry. Tob. Control, 21, 44-48.
40. Yuan, J.M. et al. (2011) Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis, 32, 1366-1371.
41. Yuan, J.M. et al. (2011) Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res., 71, 6749-6757.